Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Radiodermatitis × Hydrocortisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 2 Obesity 2 Radiodermatitis 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Silver Sulfadiazine 1 Petrolatum 1 Norepinephrine 1 Low-Level Light Therapy 1 Hydrogel, Polyethylene Glycol Dimethacrylate 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

OHSU Knight Cancer Institute

Phase NA Withdrawn

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡